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Abstract
Background: Wnt factors are a large family of signaling molecules that play important roles in the
regulation of cell fate specification, tissue polarity and cell movement. In the nervous system, Wnts
also regulates the formation of neuronal connection acting as retrograde signals that regulate the
remodeling of the axons prior to the assembly of the presynaptic apparatus. The scaffold protein
Dishevelled (Dvl) mimics the effect of Wnt on the neuronal cytoskeleton by increasing the number
of stable microtubule along the axon shaft and inducing the formation of looped microtubules (MT)
at enlarged growth cones. A divergent Wnt-Dvl canonical pathway which bifurcates downstream
of Gsk3β regulates MT dynamics.
Results: Here we show that the Wnt pathway also activates c-Jun N-terminal kinase (JNK) to
regulate MT stabilization. Although in the Wnt planar cell polarity (PCP) pathway, JNK lays
downstream of Rho GTPases, these GTPases are not required for Wnt-mediated MTs stability.
Epistatic analyses and pharmacological studies suggest that the Wnt-Dvl signalling regulates the
dynamic of the cytoskeleton through two different pathways that lead to inhibition of Gsk3β and
activation of JNK in the same cell.
Conclusion: We demonstrate a novel role for JNK in Wnt-mediated MT stability. Wnt-Dvl
pathway increases MT stability through a transcription independent mechanism that requires the
concomitant inhibition of Gsk3β and activation of JNK. These studies demonstrate that Wnts can
simultaneously activate different signalling pathways to modulate cytoskeleton dynamics.
Background
Regulation of the MT cytoskeleton is crucial for diverse
cellular functions such as cell division, cell polarity,
migration and morphogenesis. In the nervous system, reg-
ulation of the dynamic and organization of MTs is essen-
tial for the initiation, extension and maintenance of
neuronal processes. MT arrays are also used for the trans-
port of organelles and molecules along axons and den-
drites. MTs are dynamic polymers that can polymerize
and depolymerise very rapidly and this dynamic instabil-
ity allows cells to respond quickly to extracellular signals.
Although great progress has been made in understanding
how intracellular molecules regulate the dynamics of MTs
[1-3], very little is known about the mechanisms by which
extracellular signals and their pathways modulate MT
behaviour.
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The Wnt signalling pathway has been shown to directly
regulate the cytoskeletal network by regulating both the
dynamics and organization of MTs [4,5]. Wnts can func-
tion as molecules that guide axons to their appropriate
targets [6-8] but they can also function as target-derived
signals to regulate the terminal arborisation of axons
[9,10]. In the latter case, Wnt proteins act retrogradely to
inhibit axon extension and to induce the terminal remod-
elling of incoming presynaptic axons. As target-derived
signals, Wnts elicit profound changes in the organization
and stability of MTs of remodelled axons. Wnts induce
unbundling of MTs and the formation of looped MTs at
the distal portion of the axon [9,11]. Concomitantly,
Wnts increase the stability of MTs manifested by an
increased number of stable population (acetylated) of
MTs and an increased resistance to MT depolymerising
drugs [4,5]. Although initial characterization demon-
strated a role for Gsk3β, a serine/threonine kinase [4], the
mechanism by which Wnt signalling regulates the organi-
zation and stability of MTs remains poorly understood.
The signalling pathways activated by Wnts are well charac-
terized. Binding of Wnt proteins to their Frizzled receptors
activates the cytoplasmic scaffold protein Dvl. Down-
stream of Dvl, three main Wnt pathways can be activated.
In the canonical Wnt signalling pathway, Dvl induces the
disruption of the cytoplasmic complex formed by APC,
AXIN, Gsk3β and β-catenin. Dvl inhibits Gsk3β resulting
in increased stability of β-catenin, a direct target of Gsk3β.
Accumulation of β-catenin leads to its translocation to the
nucleus where, upon binding to the transcription factors
LEF or TCF, it stimulates the transcription of target genes
[12]. Wnts can also signal through the PCP pathway in
which Dvl activates small Rho GTPases resulting in the
activation of JNK [13]. In addition, Wnt proteins can sig-
nal through a calcium pathway that requires calcium
mobilization and activation of PKC [13]. Thus, Dvl mod-
ulates the activation of the three known Wnt signalling
pathways. What determines the activation of a specific
pathway is not well understood but several studies suggest
that different Wnts and their receptors confer this specifi-
city. Although activation of these pathways have been
observed in different cellular and developmental contexts,
it remains plausible that Wnt proteins could activate two
or more pathways in the same cell and that different
branches of the Wnt pathway might interact with one
another.
A divergent canonical Wnt pathway regulates MT dynam-
ics. We have shown that Wnt signalling increases MT sta-
bility through a pathway that requires Dvl and inhibition
of Gsk3β but it bifurcates downstream of Gsk3β in a tran-
scription independent manner [4,5]. Instead, Dvl acts
locally to inhibit Gsk3β, resulting in local changes in
phosphorylation levels of Gsk3β targets such as the MT-
associated protein MAP1B [5]. Consistently, phosphoryla-
tion of MAP1B by Gsk3β has been implicated in MT
dynamics [11,14]. Several lines of evidence support the
role of Gsk3β in Dvl-mediated MT stability. Firstly, expres-
sion of Gsk3β blocks the ability of Dvl to protect MTs
from depolymerization. Secondly, Dvl decreases Gsk3β
mediated phosphorylation of MAP1B, a process required
for proper modulation of MT stability. Finally, pharmaco-
logical and molecular inhibition of Gsk3β increases MT
stability. However, Gsk3β inhibition only partially mim-
ics the ability of Dvl to stabilize MTs. These findings led us
to propose that Dvl may regulate MT stability through an
additional unknown pathway [5].
To begin to characterize this additional pathway we exam-
ined the contribution of the PCP pathway. Firstly, we
tested the role of small Rho GTPases such as Rho, Rac and
Cdc42, which have been implicated in the regulation of
MT dynamics [15-21]. Interestingly, neither Rho or Rac
nor Cdc42 are required for Dvl function in MT stability. In
contrast, activation of c-Jun N-terminal kinase (JNK)
increases MT stability whereas its inhibition blocks the
ability of Dvl to stabilize MTs. Moreover, Dvl activates
endogenous JNK in developing neurons. Our results sug-
gest that Wnt-Dvl signalling activates two parallel path-
ways in the same cell to regulate MT dynamics. Dvl
increases MT stability by activating JNK and at the same
time inhibiting Gsk3β. These results demonstrate that col-
laboration between two pathways contribute to Wnt-
mediated function on the cytoskeleton.
Results
Dishevelled stabilises microtubules through inhibition of 
Gsk3β and a second signalling pathway
We have previously shown that activation of the Wnt-Dvl
signalling pathway increases MT stability in dividing and
post-mitotic cells [4,5]. Dvl fully mimics the effect of Wnts
by increasing the amount of stable MTs and inducing MT
looping and axon remodelling as observed in primary
neurons exposed to Wnts [5]. Our studies indicate that
Dvl binds to MTs and locally inhibits a pool of the Gsk3β
kinase resulting in changes in the phosphorylation of the
MT-associated protein MAP1B (Fig 1A). However, inhibi-
tion of Gsk3β is much less potent as a MT stabilizer than
Dvl [5]. Here we used neurons from differentiated neu-
roblastoma (NB2a) cells to further examine the mecha-
nism by which Dvl regulates MT stability. The resistance
of MTs to the depolymerizing drug Nocodazole [22]
assessed MT stability. Expression of Gsk3β in differenti-
ated neurons does not completely block the MT stabilis-
ing function of Dvl (Fig. 1B). Quantification shows that
expression of Gsk3β does not increase Mt stability (Fig.
1C), In contrast, Gsk3β induces almost a 30% decrease in
the ability of Dvl to stabilise MTs (Fig. 1C). This result sug-BMC Cell Biology 2007, 8:27 http://www.biomedcentral.com/1471-2121/8/27
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Dishevelled stabilises microtubules through inhibition of Gsk3β and a second signalling pathway Figure 1
Dishevelled stabilises microtubules through inhibition of Gsk3β and a second signalling pathway. A) Diagram 
shows Dvl binding to the MT network and inhibiting a pool of Gsk3β resulting in changes in the phosphorylation of MAP1B and 
increased microtubule stability. B) Neurons expressing Dvl contain stable MTs after Nocodazole treatment. Expression of 
Gsk3β partially blocks the ability of Dvl to stabilize MTs. C) Quantification shows that Dvl alone induces MT stability when 
compared to control EGFP-expressing neurons. Neurons expressing Gsk3β alone does not induce Mt stability while neurons 
expressing both Gsk3β and Dvl exhibit decreased MT stability when compared to Dvl-expressing neurons. Scale bar: 15 μm. 
Three asterisks, P < 0.001; For asterisks, P < 0.0001.BMC Cell Biology 2007, 8:27 http://www.biomedcentral.com/1471-2121/8/27
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gests that Dvl controls MT dynamics through inhibition of
Gsk3β but also through an additional pathway.
Small Rho GTPases are not required for Dishevelled-
mediated microtubule stability
To gain insight into the additional signalling pathways
required for the regulation of MT dynamics by Dvl, we
turned our attention to the family of small Rho GTPase.
WntDvl signalling has been in fact shown to regulate Rho
GTPases and these molecular switches have been impli-
cated in MT dynamics [15-21]. RhoA has been previously
shown to increase the stability of a population of MTs that
are oriented toward the leading edge of migrating cells
[16]. Therefore, we examined whether Dvl could regulate
MTs through RhoA. We reasoned that if RhoA is a possible
downstream effector of Dvl, expression of a dominant
negative mutant of RhoA, Rho N19, should block the abil-
ity of Dvl to stabilise MTs. As predicted, we found that
expression of RhoA in differentiated NB2a neurons
increases MT stability (data not shown) whereas expres-
sion of RhoN19 alone does not change MT stability com-
pared to control neurons (Fig. 2B). However, neurons
expressing both Dvl and RhoN19 still contain MTs after
nocodazole treatment (Fig. 2A, B and Additional file 1).
Quantification shows that 70% of neurons expressing
both Dvl and RhoN19 contain a large number of stable
MT similar to neurons expressing Dvl alone (Fig. 2B). To
further examine the role of RhoA, we analysed the contri-
bution of ROCK a downstream effector of Rho [23]. Over
night treatment with Y27632 a specific inhibitor of
ROCK, does not alter the ability of Dvl to stabilise MT
(Fig. 2A, B and Additional file 1). In addition, neurons
treated with ROCK inhibitor were able to extend processes
to a similar extend to control non-treated neurons (data
not shown). These results show that Dvl regulates MT sta-
bility through a Rho-independent pathway.
We next examined the contribution of Rac on Dvl-medi-
ated MT stability. Although the role for Rac in actin
dynamics is very well established, this small GTPase can
also regulate the MT network [21,24,25]. In addition,
Wnt-Dvl pathway increases the length and branching of
dendrites through the activation of Rac1 [26]. We there-
fore examined whether dominant negative Rac (RacN17)
affects Dvl function on MTs. Expression of RacN17 alone
dramatically changes the morphology of neurons as cells
exhibit shorter and spread processes (data not shown).
However, RacN17 does not increase MT stability in NB2a
neurons (Fig. 2B). Importantly, neurons expressing both
Dvl and RacN17 are still able to retain MTs after nocoda-
zole treatment to similar levels to those neurons express-
ing Dvl alone (Fig. 2A, B and Additional file 1). These
results suggest that Rac1 is not required for the regulation
of MT dynamics by Dvl.
Recently Cdc42 has been shown to regulate the MT net-
work by increasing the capture of the plus-ends of MTs
through +TIPs proteins such as CLIP170 and the actin
binding protein IQGAP [27]. In addition, Cdc42 regulates
cell migration through a signalling pathway that required
Gsk3β and APC [28]. As both Gsk3β and APC are compo-
nents of the Wnt canonical pathway, we examined
whether Cdc42 is required for Dvl-mediated MT stabiliza-
tion. Expression of a dominant negative form of Cdc42
(Cdc42N17) does not affect the level of MT stability when
compared to control neurons expressing EGFP (Fig. 2B).
As observed with Rho and Rac, expression of Cdc42N17
does not affect Dvl function (Fig. 2A and Additional file
1). Quantification reveals that 65% of neurons expressing
only Dvl have stable MTs after nocodazole compared to
60% of neurons expressing Cdc42N17 and Dvl (Fig. 2B).
These results suggest that Cdc42 is not required by Dvl to
regulate MT dynamics. Taken together these findings
strongly suggest that Dvl regulates MT stability independ-
ently of Rho GTPases.
Activation of the JNK pathway is required for microtubule 
stability mediated by Dishevelled
JNK is an important component of the non-canonical
PCP Wnt signalling pathway that regulates cell polarity,
cell migration and dendritic development [13,26].
Although JNK has mainly been studied for its role in
apoptosis and transcriptional regulation, recent studies
have demonstrated that JNK can directly modulate the
cytoskeleton. JNK phosphorylates MT-associated proteins
such as MAP2 and MAP1B resulting in changes in MT
dynamics [29]. In the Wnt signalling pathway JNK is often
considered a downstream target of Rac [30,31] but JNK
can also act independently of Rac [32]. On the basis of
these findings, we investigated the contribution of JNK to
Dvl-mediated MT stability. We first examined whether
activation of JNK alone was able to induce MT stability.
Differentiated NB2a neurons expressing EGFP were
treated with Anisomycin, a direct activator of JNK when
used a low concentrations [26,33,34]. In the presence of
Anisomycin, a significant number of cells contain stable
MTs after Nocodazole treatment when compared to con-
trols (Fig. 3A and Additional file 2). Moreover, expression
of full-length JNK increases MT stability to comparable
levels as Anisomicin-treated neurons (Fig 3A and Addi-
tional file 1). Quantification shows that almost 30% of
neurons treated with Anisomicin and 32% of neurons
expressing JNK have stable MTs in the cell body and along
the axon whereas only 8% of control cells contain MTs in
the presence of Nocodazole (Fig 3B). This result demon-
strates that activation of JNK increases MT stability.
To further test the role of JNK, we asked whether inhibi-
tion of JNK affects the function of Dvl in MT stability.
SP600125, a specific JNK inhibitor [35] and expression ofBMC Cell Biology 2007, 8:27 http://www.biomedcentral.com/1471-2121/8/27
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the JNK dominant negative JBD [36] were used. Inhibi-
tion of JNK with SP600125 decreases the ability of Dvl to
protect the MT network from Nocodazole to 38% (Fig.
3C, D and Additional file 2). Similarly, expression of JBD
decreases the number of Dvl-expressing cells containing
stable MT to 40% compare to the 60–65% induced by
expression of Dvl alone (Fig. 3C, D and Additional file 2).
These results suggest that the inhibition of the JNK path-
way blocks Dvl function on MT stability.
We then examined whether Dvl can activate endogenous
JNK in neurons. The level of phosphorylation of c-Jun was
used as a read out of JNK activity [26]. As the activation of
JNK might be time dependent, we used the Dvl-ER induc-
ible system in which the levels of active Dvl can be regu-
lated in a time-specific manner. Dvl-ER is a fusion
construct in which full length Dvl has been fused to the
estrogen receptor such that active Dvl protein is obtained
upon induction with β-estradiol [5]. We have previously
used this system and found that Dvl becomes active and
stabilises MTs in axons after 3 hrs of induction with β-
estradiol [5]. Therefore, we examined the levels of phos-
phorylated c-Jun after different periods of induction. To
exclude possible non-specific effects of β-estradiol on MT
stability, untransfected control neurons were exposed to
β-estradiol for three hrs and the level of p-c-Jun was
assessed by western blot (Fig. 4A and 4B). Neurons
exposed to β-estradiol exhibit the same level of p-c-Jun as
untreated control neurons (Fig 4A and 4B). Treatment of
Dvl-ER expressing neurons with β-estradiol for 1 hr does
not increase the level of p-c-Jun when compared with
EGFP-expressing neurons (Fig 4A and 4B), In contrast, the
level of cJun phosphorylation increases by 40% after 3 hrs
of β-estradiol treatment (Fig 4A and 4B) to levels compa-
rable to the activation of JNK using Anisomicin (Fig 4A
and 4B). Importantly, the level of total c-Jun does not
change in both neurons treated with β-estradiol for 3 hrs
or Anisomicin when compared to control (Fig 4A). Taken
together these results suggest that Dvl activates JNK.
To further examine the role of Wnt-Dvl signalling on JNK
activation, we examined the level of active JNK using spe-
cific antibodies that detect p-JNK. We decided to test
directly the levels of active JNK on MTs along the axons. A
specific fixation protocol was used to preserve only the
cytoskeleton but removing any cytosolic components.
Immunofluorescence analyses show that Dvl colocalises
with active JNK on the cytoskeleton (Fig 4C). In addition,
Dvl expression increases the level of p-JNK bound to the
cytoskeleton when compared to EGFP transfected control
cells (Fig 4C). These results strongly suggest that Dvl
increases the level of active JNK associated with MTs.
small GTPases are not required for MT stability induced by  Dvl Figure 2
small GTPases are not required for MT stability 
induced by Dvl. A) Neurons expressing Dvl alone exhibit 
increased microtubule stability when compared to control 
EGFP-expressing neurons. Expression of dominant negative 
Rho (RhoN19), dominant negative Rac (RacN17), and domi-
nant negative Ccd42 (Cdc42 N17) do not alter the ability of 
Dvl to stabilise microtubules. In addition, neurons expressing 
Dvl and treated with the ROCK inhibitor Y27632 exhibit 
comparable level of microtubule stability as untreated Dvl-
expressing neurons. All neurons were treated with Nocoda-
zole to test MT stability B) Quantification shows that coex-
pression of Dvl together with dominant negative Rac Rho, or 
Cdc42 or the ROCK inhibitor does not change the ability of 
Dvl to stabilise MTs. Scale bar: 15 μm.BMC Cell Biology 2007, 8:27 http://www.biomedcentral.com/1471-2121/8/27
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Activation of JNK induces MT stability while inhibition of JNK blocks MT stability by Dvl Figure 3
Activation of JNK induces MT stability while inhibition of JNK blocks MT stability by Dvl. A) EGFP-expressing con-
trol neurons treated with low concentration of Anisomicin show higher level of microtubule stability when compared to EGFP-
expressing neurons. Neurons expressing JNK alone reveals a level of stability comparable to that one obtained after exposure 
of neurons to Anisomicin. B) Quantification shows that Anisomicin treatment and JNK expression increase the level of MT 
stability in neurons C) Dvl-expressing neurons treated with the JNK inhibitor SP600125 or expressing the dominant negative 
JNK (JBD) show decreased MT stability when compared to control Dvl-expressing neurons. D) Quantification shows that 
treatment of Dvl expressing neurons with JNK inhibitor SP 600125 or expression of JBD reduces the level of MT stability. 
Scale bar 15 μm. Three asterisks, P < 0.001; For asterisks, P < 0.0001.BMC Cell Biology 2007, 8:27 http://www.biomedcentral.com/1471-2121/8/27
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Dvl expression activates JNK Figure 4
Dvl expression activates JNK. A) Induction of Dvl-ER expression for three hours with β-estradiol increases the level of p-
c-Jun, a read-out of endogenous JNK activity, when compared to controls. Low levels of Anisomicin also increase the level of 
p-c-Jun when compared with control untreated EGFP-expressing neurons or neurons exposed to β-estradiol for three hrs. 
However, the levels of total c-Jun remain unchanged. B) Quantification of three independent experiments shows that induc-
tion of Dvl-ER expression induces a 40% increase in p-c-Jun levels compare to control. C) Expression of Dvl increases the level 
of p-JNK decorating the MT network along neurites when compared to EGFP-expressing control neurons. Pseudocolor panels 
show Dvl increases the level of p-JNK associated with microtubules. Scale bar 5 μm. Two asterisks, P < 0.01.BMC Cell Biology 2007, 8:27 http://www.biomedcentral.com/1471-2121/8/27
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The DEP domain of Dishevelled is dispensable for 
signalling to JNK
The Dvl protein has three main conserved domains that
are required for signalling through different branches of
the Wnt pathway [37,38]. Many studies have shown that
DIX and PDZ domains of Dvl are required for the canon-
ical Wnt pathway whereas the DEP domain is required for
the PCP pathway [31,39]. However, the correlation
between domains and the activation of specific Wnt path-
ways has proved to be more complex. For example, in
some systems the DEP domain is required for the canoni-
cal pathway [37,39]. Similarly, the PDZ domain can acti-
vate the non-canonical pathway [26,31,38]. In the
divergent canonical pathway, the PDZ domain is required
for Dvl-Gsk3β mediated MT stability [4]. To begin to
understand how Dvl signals through JNK, we have exam-
ined the contribution of the different domains of Dvl on
JNK-mediated MT stability. NB2a cells expressing full
length Dvl and mutant forms of Dvl lacking the DIX, PDZ
or DEP domains were examined for their ability to stabi-
lize MTs in the absence or presence of the JNK inhibitor
SP600125. We found that neurons expressing ΔDEP-Dvl
exhibit similar levels of MT stability to cells expressing full
length Dvl (Fig. 5A and 5B). However, inhibition of JNK
blocks this effect to control levels (Fig 5A, B and Addi-
tional file 3). In contrast, expression of ΔDIX-Dvl and
ΔPDZ-Dvl only confers a level of stability of 48% and
38% respectively (Fig. 5A and 5B). Importantly the pres-
ence of the JNK inhibitor does not change the level of sta-
bility conferred by these two deletion mutants (Fig. 5A, B
and Additional file 3). Taken together these results suggest
that the PDZ domain and, to a lesser extend the DIX
domain, are required for signalling through JNK, whereas
the DEP domain is dispensable.
Is the domain responsible for MTs stability also required
for the binding of Dvl to MTs? To answer this question we
examined the ability of full length and mutant forms of
Dvl to bind to MTs. We found that full-length Dvl as well
ΔDEP-Dvl and ΔDIX-Dvl remain tightly associated with
MTs upon detergent fixation, a protocol that retains MTs
associated proteins (Fig. 5C and data not shown). In con-
trast, ΔPDZ-Dvl mutant remains poorly associated with
MTs when compare with ΔDEP-Dvl and Dvl full length
(Fig 5C). Taken together these results suggest that the PDZ
domain of Dvl is required for MT binding and also for MT
stability.
Dishevelled regulates microtubule stability through two 
distinct pathways
We have previously shown that expression of Gsk3β
decreases the ability of Dvl to stabilise MTs to 35–40%
(Fig. 1C) [4]. We therefore asked whether this residual
level of stability is due to signalling through the JNK. We
found that inhibition of JNK with SP600125 decreases
further the ability of Dvl to stabilise MTs when Gsk3β is
already expressed (Fig. 6A and 6B). These results suggest
that activation of JNK and inhibition of Gsk3β contribute
together to Dvl-mediated MT stability.
Gsk3β and JNK could be part of the same pathway or may
act in distinct pathways to modulate MT dynamics. To dis-
tinguish between these two alternatives, we tested
whether activation of JNK can override the effect of Gsk3β
on Dvl function. We found that activation of JNK with
Anisomicin does not change the level of MTs stability
observed when Dvl and Gsk3β are expressed together (Fig.
6C) suggesting that JNK is not downstream of Gsk3β to
regulate MT dynamics.
To examine if JNK is upstream of Gsk3β, we investigated
whether JNK affects the levels of Gsk3β-mediated phos-
phorylation of MAP1B, which is correlated with MT stabil-
ity and more importantly with the level of Gsk3β activity
[11]. For these experiments we used granule cell neurons
in which specific antibodies can recognise one of the
Gsk3β phosphorylation site in MAP1B [11]. We found
that expression of JBD does not affect the ability of Dvl to
inhibit MAP1B phosphorylation (Fig. 6D). This result sug-
gests that JNK does not affect Gsk3β activity and therefore
it is not upstream of Gsk3β. We then asked if JNK activity
was affected by Gsk3β by examining the level of phospho-
rylation of c-Jun in cells expressing Gsk3β. Western blot
analyses show that Gsk3β does not change the levels of
phosphorylated c-Jun at either 3 or 16 hrs after transfec-
tion (data not shown). Taken together these results sug-
gest that increased MT stability by Dvl is achieved through
inhibition of Gsk3β and activation of JNK and that the
two pathways are acting independently to regulate the MT
cytoskeleton.
Discussion
Here we show that Wnt-Dvl signalling regulates MT
dynamics through two distinct pathways. Dvl induces the
concomitant inhibition of Gsk3β and the activation of
JNK to increase MT stability. The typical PCP pathway
appears not to be involved as small Rho GTPases are not
required for this function. These findings highlight a new
role for JNK kinase in the modulation of the MT dynamics
mediated by Wnt signaling.
We have previously showed that a divergent canonical
Wnt pathway regulates MT dynamics. The scaffold protein
Dvl is tightly associated with MTs [4] and increases MT
stability through the local inhibition of a pool of Gsk3β
[5]. In turn, inhibition of Gsk3β by Wnt or expression of
Dvl leads to changes in the phosphorylation of MAPs,
notably MAP1B, resulting in increased MT stability.
Although pharmacological inhibition of Gsk3β increases
MT stability, this effect is weaker than that observed byBMC Cell Biology 2007, 8:27 http://www.biomedcentral.com/1471-2121/8/27
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The PDZ domain and at lesser extent the DIX domains of Dvl are required for activation of JNK Figure 5
The PDZ domain and at lesser extent the DIX domains of Dvl are required for activation of JNK. A) Neurons 
expressing Dvl full-length or Dvl mutants carrying deletions of the DIX, PDZ or DEP domains were treated with or without 
the JNK inhibitor SP600125 and MT stability was examined after Nocodazole treatment. B) Quantification shows that neurons 
expressing ΔDIX or ΔPDZ mutants and treated with SP600125 exhibit the same low level of MT stability as untreated neurons. 
Conversely, neurons expressing ΔDEP-Dvl mutant and treated with SP600125 show lower level of MT stability than control 
untreated neurons. C) Full length Dvl and ΔDEP-Dvl bind to MTs along the axon whereas low levels of ΔPDZ-Dvl mutant 
remains associated to MTs after detergent fixation. Scale bar 15 μm. Three asterisks, P < 0.001.BMC Cell Biology 2007, 8:27 http://www.biomedcentral.com/1471-2121/8/27
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Dvl signals through two parallel pathways to regulate microtubule stability by Dvl Figure 6
Dvl signals through two parallel pathways to regulate microtubule stability by Dvl. A) Neurons expressing Dvl an 
Gsk3β and treated with JNK inhibitor lose the residual level of MTs when compare with neurons expressing Dvl and Gsk3β. 
Scale bar 15 μm. B) Quantification shows that neurons expressing Dvl and Gsk3β and treated with JNK inhibitor have a 
decreased level of MTs stability than untreated neurons expressing Dvl and Gsk3β. C) Quantification shows that neurons 
expressing Dvl together with Gsk3β and treated with Anisomicin have comparable level of MT stability as untreated neurons. 
D) Inhibition of JNK by expression of JBD does not affect the level of phosphorylated MAP1B in granule cell neurons express-
ing Dvl when compared to control neurons expressing Dvl alone (arrow). Scale bar 10 μm. Two asterisks, P < 0.01; Three 
asterisks, P < 0.001.BMC Cell Biology 2007, 8:27 http://www.biomedcentral.com/1471-2121/8/27
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expression of Dvl. Moreover, expression of Gsk3β only
partially blocks the ability of Dvl to stabilize MTs [5].
These findings suggest that in addition to Gsk3β, Wnt-Dvl
signals through another pathway to regulate MT dynam-
ics.
The family of the small Rho GTPases are not required for
the regulation of MT stability upon Wnt activation.
Although small Rho GTPases have been extensively
shown to control different aspects of actin dynamic and
organisation [18,40-43], these molecules can also regulate
the MT network. For example RhoA and its effector mDia
are necessary for MT stability induced by LPA and activa-
tion of integrins [16,44,45]. Conversely Rac and Cdc42
signalling through their effectors PAK and IQGAP respec-
tively are required for the capture of MT plus-end at the
leading edge of migrating cells [27] and for inhibition of
the MT destabilising effect of Stathmin (OP18)
[17,21,46]. Recently Cdc42 and RhoA have been shown
to regulate the phosphorylation of Gsk3β to control MT
stability and cell polarisation [28,47]. Importantly, the
PCP pathway activates small Rho GTPases to regulate tis-
sue polarity, cell migration and dendritic morphogenesis,
processes that require the reorganization of the cytoskele-
ton [26,31,48]. However, expression of Rho, Rac or Cdc42
dominant-negative mutants does not alter the ability of
Dvl to stabilise MTs. Thus, Wnt-Dvl signalling regulates
MT stability through a Rho GTPase independent pathway.
Wnt signalling regulates MT stability through JNK. In neu-
rons, activation of JNK increases MT stability whereas
pharmacological inhibition of JNK or expression of a
dominant-negative form of JNK blocks the effect of Dvl
on MT stability. In the PCP pathway, JNK is downstream
of Rho GTPases [30,31]. However, the finding that small
GTPases are not required for MT stabilization by Dvl sug-
gests that activation of JNK is achieved independently of
these small GTPases. Interestingly, studies have shown
that Dvl can activate JNK in a Rac and Cdc42 independent
manner [32]. This is the first demonstration that Wnt sig-
nalling regulates MT stability through JNK.
The same domains of Dvl are required for signalling to
JNK and Gsk3β to modulate MT dynamics. We have pre-
viously shown that the PDZ and DIX domains of Dvl are
important for signalling through Gsk3β [4]. Here we show
that the PDZ is required for binding of Dvl to the MT net-
work. Moreover, the PDZ and DIX domains are also
required for Dvl to signal to JNK. It has been generally
accepted that PDZ domain of Dvl is required for the acti-
vation of the Gsk3β/β-catenin pathway whereas the DEP
domain is required for the PCP pathway [37,39]. How-
ever, several studies have shown that the PDZ domain of
Dvl is also required for the PCP pathway [26,31,38] sug-
gesting that different domains of Dvl can activate different
Wnt signalling pathways depending on the cellular or
developmental context. Thus, our finding that Dvl signals
to JNK through its PDZ and DIX domains raises the possi-
bility that Gsk3β and JNK act together to regulate MT
dynamics.
How does JNK modulate MT dynamics? JNK could regu-
late MT stability through changes in gene expression or
through direct signalling to the cytoskeleton. JNK has
been well established as a key regulator of transcription
[49,50]. However, we found that Wnt regulates MT stabil-
ity through a transcription-independent pathway [5] sug-
gesting that the Wnt pathway through JNK directly signals
to the cytoskeleton. Consistently, we found that Dvl
increases the level of active JNK associated with MTs sug-
gesting that JNK can directly modulate the MT network
[51,52] by changing the phosphorylation of MT associ-
ated proteins such as MAP2 and MAP1B [29]. Moreover,
Wnt signalling regulates the phosphorylation of MAPs
suggesting that JNK could mediate these changes. Future
studies will elucidate the targets of JNK in this novel Wnt
pathway.
Two different pathways that include JNK and Gsk3β con-
tribute to Wnt-mediated effects on MT dynamics. Epistatic
analyses show that the concomitant expression of Gsk3β
and pharmacological inhibition of JNK strongly blocks
the ability of Dvl to stabilize MTs. Interestingly, activation
of Gsk3β or inhibition of JNK alone partially blocks Dvl
function. These findings indicate that these two kinases
are both required to regulate MTs stability via Dvl. Inter-
estingly JNK is not downstream of Gsk3β as activation of
JNK does not alter the ability of Gsk3β to block MT stabil-
ity induced by Dvl. Moreover when JNK is blocked, Dvl is
still able to inhibit Gsk3β activity as determined by the
level of MAP1B phosphorylation. Conversely when Gsk3β
is expressed in neurons the activity of JNK is not altered.
Taken together these findings suggest that JNK regulates
the cytoskeleton through a distinct pathway that is inde-
pendent of Gsk3β. In summary, our studies demonstrate
a novel role for JNK in Wnt-mediated MT stability and
demonstrate that Wnts can simultaneously active differ-
ent signalling branches to modulate complex cellular
processes.
Conclusion
Here we report that Wnt-Dvl signaling activates two differ-
ent pathways to modulate MT dynamics. Concomitant
inhibition of Gsk3β and activation of JNK mediates the
effect of Wnts on MT stability. Interestingly the small Rho
GTPases are not required for Wnt-Dvl signaling to the MT
network suggesting that an atypical non-canonical path-
way is involved in MT stability.BMC Cell Biology 2007, 8:27 http://www.biomedcentral.com/1471-2121/8/27
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Methods
Transient transfections and plasmid constructs
Full length Dvl1, Dvl1 deletion mutants, and Gsk3β were
under the control of the CMV promoter [4]. Rho, Rac,
Cdc-42 constructs were provided by Dr C. Nobes. Full-
length JNK and dominant negative JNK-1 (JBD) construct
were kindly provided by Roger Davis. Plasmids for trans-
fection were isolated using a maxi-prep endotoxin-free kit
(QIAGEN).
Cell Cultures and transfection
NB2a cells were maintained in DMEM containing 10%
FCS at 37°C and 5% CO2. For immuno-fluorescence
analyses cells were cultured on glass coverslips and tran-
siently transfected using Lipofectamin (Invitrogen) for 3
hrs. NB2a cells were then differentiated into neurons by
overnight treatment with 1 μM dibutyryl-cyclic-AMP and
then fixed For MT stability assay, NB2a neurons were
treated with 5 μM Nocodazole for 30 minutes at 37°C and
then fixed. To inhibit JNK, neurons were treated with the
specific JNK inhibitor SP600125 (Tocris Co) at 10 μM.
JNK inhibitor was added 16 hrs after transfection and left
for 9 hrs. This period of treatment was chosen because
cells transfected with EGFP and treated with SP600125
contain a similar amount of stable MTs to control EGFP
expressing cells after Nocodazole treatment. To activate
JNK, neurons were treated with Anisomicin (10 mg/ml) 4
hrs before fixation. To inhibit ROCK, neurons were
treated with ROCK inhibitor Y27632 (Calbiochem) (100
mM) 3 hrs after transfection and left 15 hrs before fixa-
tion.
Immunofluorescence microscopy
Neurons were fixed in 4% PFA/4% sucrose at room tem-
perature for 20 minutes, permeabilised with 0.02% Tri-
ton-X-100 for 5 minutes and blocked in 5% BSA in PBS
for 1 hour. To examine the association of proteins to the
cytoskeleton, neurons were fixed for 10' at 37C with deter-
gent fixation buffer containing 3% Formaldehyde, 0.2%
Gluteraldehyde, 0.2% Triton X 100 and 10 mM EGTA Ph
7.2. Neurons were then permeabilized with 0.02% triton
for 2' before blocking. Primary antibodies against
acetylated tubulin (Sigma), tyrosinated tubulin (Oxford
Biotechnology), HA (Boeringher Mannheim), Myc, Flag
(Sigma), phosphorylated MAP-1B (SMI 31) (Affinity
BioReagents, Inc) were used. Secondary antibodies
Alexa488, Alexa546 and Alexa 350 from Molecular Probes
were used.
Western blots
For western blot analyses, neurons were plated on plastic
dishes and 24 hrs after transfection was lysed in RIPA
buffer containing 100 μg/ml PMSF, 10 μg/ml aprotinin,
10 μg/ml pepstatin, and 10 μg/ml leupeptin. After protein
quantification samples were analysed by SDS-PAGE and
western blots. When the inducible Dvl-ER system [53] was
used, differentiated neurons were treated with 1 μM β-
estradiol for different periods of times. Monoclonal anti-
body against p-c-Jun (KM-1), c-Jun and tubulin (ab6161)
were from Santa Cruz Biotechnology (Santa Cruz CA) and
ABCAM respectively. Anti-mouse or anti-rat Ighorseradish
peroxidase and chemoluminescence (ECL) solution
(Amersham) were used for protein detection. Western
blots were scanned, and the optical density of each band
was quantified using NIH Image software. Each experi-
ment was done at least 3 times.
Analyses of microtubule stability
Neurons were transfected with the appropriate plasmids
and, 16 hrs after transfection, they were treated with 5 μM
Nocodazole for 30 minutes at 37°C, a condition that
results in the depolymerization of most MTs in neurons.
Stable MTs were stained using an antibody against
acetylated tubulin. Neurons containing MTs in both the
cell body and along the processes were considered posi-
tive for MT stability and given a value of 1 for quantifica-
tion. Neurons containing low level of MTs or MTs only in
the cell body or axon were given a value of 0.5. The per-
centage of MT stability was defined as the ratio between
total number of neurons and those containing MTs. At
least 100 cells were counted per experiment and each
experiment was repeated at least 3 times.
Primary neuron isolation and transfections
Cerebella granule cells from neonatal mice were obtained
as described previously [54]. Briefly, after dissection, 5 ×
104 cells were plated on coverslips previously treated with
500 μg/ml poly-D-lysine for 1 hour and 30 μg/ml laminin
for 3 hrs at room temperature. After 2 days in vitro, neu-
rons were transiently transfected using Lipofectamine
2000 (Invitrogen) for 2 hrs and were cultured for an addi-
tional 24 hrs previous fixation.
Image acquisition and Statistical analysis
Images were captured with an Olympus BX60 or an
inverted Zeiss M 200 microscope using a CCD camera
(Orca ER), acquired with Metamorph software and proc-
essed with Adobe Photoshop. For each experiment more
than 100 cells were analysed and the data correspond to
at least three different experiments. Data was subject to
analysis of variance (ANOVA). Different levels of signifi-
cances were labelled as followed (For asterisks p < 0.0001;
Three asterisks p < 0.001; Two asterisks p < 0.01 and one
asterisks p < 0.05).
Authors' contributions
LC carried out all the experiments, participated in the
design of the study and in the draft of the manuscript; PS
conceived the study, participated in its design and helpedBMC Cell Biology 2007, 8:27 http://www.biomedcentral.com/1471-2121/8/27
Page 13 of 14
(page number not for citation purposes)
to draft the manuscript. LC and PS have both read and
approved the final manuscript.
Additional material
Acknowledgements
We would like to thank C. Nobes and R. Davis for constructs. We also 
thank members of our laboratory for useful discussion and comments on 
the manuscript. The Wellcome Trust supported this work.
References
1. da Silva JS, Dotti CG: Breaking the neuronal sphere: regulation
of the actin cytoskeleton in neuritogenesis.  Nat Rev Neurosci
2002, 3(9):694-704.
2. Dent EW, Gertler FB: Cytoskeletal dynamics and transport in
growth cone motility and axon guidance.  Neuron 2003,
40(2):209-227.
3. Galjart N: CLIPs and CLASPs and cellular dynamics.  Nat Rev
Mol Cell Biol 2005, 6(6):487-498.
4. Krylova O, Messenger MJ, Salinas PC: Dishevelled-1 regulates
microtubule stability: a new function mediated by glycogen
synthase kinase-3beta.  J Cell Biol 2000, 151(1):83-94.
5. Ciani L, Krylova O, Smalley MJ, Dale TC, Salinas PC: A divergent
canonical WNT-signaling pathway regulates microtubule
dynamics: dishevelled signals locally to stabilize microtu-
bules.  J Cell Biol 2004, 164(2):243-253.
6. Schmitt AM, Shi J, Wolf AM, Lu CC, King LA, Zou Y: Wnt-Ryk sig-
nalling mediates medial-lateral retinotectal topographic
mapping.  Nature 2006, 439(7072):31-37.
7. Liu  Y, Shi  J, Lu CC, Wang ZB, Lyuksyutova AI, Song XJ, Zou Y: Ryk-
mediated Wnt repulsion regulates posterior-directed
growth of corticospinal tract.  Nat Neurosci 2005, 8(9):1151-9.
8. Lyuksyutova AI, Lu CC, Milanesio N, King LA, Guo N, Wang Y, Nath-
ans J, Tessier-Lavigne M, Zou Y: Anterior-posterior guidance of
commissural axons by Wnt-frizzled signaling.  Science 2003,
302(5652):1984-1988.
9. Hall AC, Lucas FR, Salinas PC: Axonal remodeling and synaptic
differentiation in the cerebellum is regulated by WNT-7a
signaling [see comments].  Cell 2000, 100(5):525-535.
10. Krylova O, Herreros J, Cleverley K, Ehler E, Henriquez J, Hughes S,
Salinas P: WNT-3, Expressed by Motoneurons, Regulates Ter-
minal Arborization of Neurotrophin-3-Responsive Spinal
Sensory Neurons.  Neuron 2002, 35(6):1043.
11. Lucas FR, Goold RG, Gordon-Weeks PR, Salinas PC: Inhibition of
GSK-3beta leading to the loss of phosphorylated MAP-1B is
an early event in axonal remodelling induced by WNT-7a or
lithium.  J Cell Sci 1998, 111(Pt 10):1351-1361.
12. Logan CY, Nusse R: The Wnt signaling pathway in develop-
ment and disease.  Annu Rev Cell Dev Biol 2004, 20:781-810.
13. Wallingford JB, Habas R: The developmental biology of Dishev-
elled: an enigmatic protein governing cell fate and cell polar-
ity.  Development 2005, 132(20):4421-4436.
14. Goold RG, Owen R, Gordon-Weeks PR: Glycogen synthase
kinase 3beta phosphorylation of microtubule-associated
protein 1B regulates the stability of microtubules in growth
cones.  J Cell Sci 1999, 112 ( Pt 19):3373-3384.
15. Narumiya S, Yasuda S: Rho GTPases in animal cell mitosis.  Curr
Opin Cell Biol 2006, 18(2):199-205.
16. Cook TA, Nagasaki T, Gundersen GG: Rho guanosine triphos-
phatase mediates the selective stabilization of microtubules
induced by lysophosphatidic acid.  J Cell Biol 1998,
141(1):175-185.
17. Wittmann T, Bokoch GM, Waterman-Storer CM: Regulation of
leading edge microtubule and actin dynamics downstream of
Rac1.  J Cell Biol 2003, 161(5):845-851.
18. Nobes CD, Hall A: Rho GTPases control polarity, protrusion,
and adhesion during cell movement.  J Cell Biol 1999,
144(6):1235-1244.
19. Linder S, Hufner K, Wintergerst U, Aepfelbacher M: Microtubule-
dependent formation of podosomal adhesion structures in
primary human macrophages.  J Cell Sci 2000, 113 Pt
23:4165-4176.
20. Tian L, Nelson DL, Stewart DM: Cdc42-interacting protein 4
mediates binding of the Wiskott-Aldrich syndrome protein
to microtubules.  J Biol Chem 2000, 275(11):7854-7861.
21. Daub H, Gevaert K, Vandekerckhove J, Sobel A, Hall A: Rac/Cdc42
and p65PAK regulate the microtubule-destabilizing protein
stathmin through phosphorylation at serine 16.  J Biol Chem
2001, 276(3):1677-1680.
22. Hoebeke J, Van Nijen G, De Brabander M: Interaction of oncoda-
zole (R 17934), a new antitumoral drug, with rat brain tubu-
lin.  Biochem Biophys Res Commun 1976, 69(2):319-324.
23. Fujisawa K, Fujita A, Ishizaki T, Saito Y, Narumiya S: Identification
of the Rho-binding domain of p160ROCK, a Rho-associated
coiled-coil containing protein kinase.  J Biol Chem 1996,
271(38):23022-23028.
24. Watabe-Uchida M, John KA, Janas JA, Newey SE, Van Aelst L: The
Rac activator DOCK7 regulates neuronal polarity through
local phosphorylation of stathmin/Op18.  Neuron 2006,
51(6):727-739.
25. Eaton S, Wepf R, Simons K: Roles for Rac1 and Cdc42 in planar
polarization and hair outgrowth in the wing of Drosophila.  J
Cell Biol 1996, 135(5):1277-1289.
26. Rosso SB, Sussman D, Wynshaw-Boris A, Salinas PC: Wnt signaling
through Dishevelled, Rac and JNK regulates dendritic devel-
opment.  Nat Neurosci 2005, 8(1):34-42.
27. Fukata M, Watanabe T, Noritake J, Nakagawa M, Yamaga M, Kuroda
S, Matsuura Y, Iwamatsu A, Perez F, Kaibuchi K: Rac1 and Cdc42
capture microtubules through IQGAP1 and CLIP-170.  Cell
2002, 109(7):873-885.
28. Etienne-Manneville S, Hall A: Cdc42 regulates GSK-3beta and
adenomatous polyposis coli to control cell polarity.  Nature
2003, 421(6924):753-756.
29. Chang L, Jones Y, Ellisman MH, Goldstein LS, Karin M: JNK1 is
required for maintenance of neuronal microtubules and con-
trols phosphorylation of microtubule-associated proteins.
Dev Cell 2003, 4(4):521-533.
30. Moriguchi T, Kawachi K, Kamakura S, Masuyama N, Yamanaka H,
Matsumoto K, Kikuchi A, Nishida E: Distinct domains of mouse
dishevelled are responsible for the c-Jun N-terminal kinase/
stress-activated protein kinase activation and the axis for-
mation in vertebrates.  J Biol Chem 1999, 274(43):30957-30962.
31. Habas R, Dawid IB, He X: Coactivation of Rac and Rho by Wnt/
Frizzled signaling is required for vertebrate gastrulation.
Genes Dev 2003, 17(2):295-309.
32. Li L, Yuan H, Xie W, Mao J, Caruso AM, McMahon A, Sussman DJ,
Wu D: Dishevelled proteins lead to two signaling pathways.
Regulation of LEF-1 and c-Jun N-terminal kinase in mamma-
lian cells.  J Biol Chem 1999, 274(1):129-134.
33. Iordanov MS, Pribnow D, Magun JL, Dinh TH, Pearson JA, Chen SL,
Magun BE: Ribotoxic stress response: activation of the stress-
activated protein kinase JNK1 by inhibitors of the peptidyl
transferase reaction and by sequence-specific RNA damage
Additional file 1
single black and white panels of colour merged images of Figure 2
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2121-8-27-S1.tiff]
Additional file 2
single black and white panels of colour merged images of Figure 3
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2121-8-27-S2.tiff]
Additional file 3
single black and white panels of colour merged images of Figure 5
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2121-8-27-S3.tiff]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Cell Biology 2007, 8:27 http://www.biomedcentral.com/1471-2121/8/27
Page 14 of 14
(page number not for citation purposes)
to the alpha-sarcin/ricin loop in the 28S rRNA.  Mol Cell Biol
1997, 17(6):3373-3381.
34. Coffey ET, Hongisto V, Dickens M, Davis RJ, Courtney MJ: Dual
roles for c-Jun N-terminal kinase in developmental and
stress responses in cerebellar granule neurons.  J Neurosci
2000, 20(20):7602-7613.
35. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W,
Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM,
Anderson DW: SP600125, an anthrapyrazolone inhibitor of
Jun N-terminal kinase.  Proc Natl Acad Sci U S A 2001,
98(24):13681-13686.
36. Dickens M, Rogers JS, Cavanagh J, Raitano A, Xia Z, Halpern JR,
Greenberg ME, Sawyers CL, Davis RJ: A cytoplasmic inhibitor of
the JNK signal transduction pathway.  Science 1997,
277(5326):693-696.
37. Yanagawa S, van Leeuwen F, Wodarz A, Klingensmith J, Nusse R: The
dishevelled protein is modified by wingless signaling in Dro-
sophila.  Genes Dev 1995, 9(9):1087-1097.
38. Penton A, Wodarz A, Nusse R: A mutational analysis of dishev-
elled in Drosophila defines novel domains in the dishevelled
protein as well as novel suppressing alleles of axin.  Genetics
2002, 161(2):747-762.
39. Axelrod JD, Miller JR, Shulman JM, Moon RT, Perrimon N: Differen-
tial recruitment of Dishevelled provides signaling specificity
in the planar cell polarity and Wingless signaling pathways.
Genes Dev 1998, 12(16):2610-2622.
40. Pollard TD, Blanchoin L, Mullins RD: Molecular mechanisms con-
trolling actin filament dynamics in nonmuscle cells.  Annu Rev
Biophys Biomol Struct 2000, 29:545-576.
41. Ridley AJ, Hall A: The small GTP-binding protein rho regulates
the assembly of focal adhesions and actin stress fibers in
response to growth factors.  Cell 1992, 70(3):389-399.
42. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A: The small
GTP-binding protein rac regulates growth factor-induced
membrane ruffling.  Cell 1992, 70(3):401-410.
43. Kozma R, Ahmed S, Best A, Lim L: The Ras-related protein
Cdc42Hs and bradykinin promote formation of peripheral
actin microspikes and filopodia in Swiss 3T3 fibroblasts.  Mol
Cell Biol 1995, 15(4):1942-1952.
44. Palazzo AF, Cook TA, Alberts AS, Gundersen GG: mDia mediates
Rho-regulated formation and orientation of stable microtu-
bules.  Nat Cell Biol 2001, 3(8):723-729.
45. Palazzo AF, Eng CH, Schlaepfer DD, Marcantonio EE, Gundersen GG:
Localized stabilization of microtubules by integrin- and FAK-
facilitated Rho signaling.  Science 2004, 303(5659):836-839.
46. Wittmann T, Bokoch GM, Waterman-Storer CM: Regulation of
microtubule destabilizing activity of Op18/stathmin down-
stream of Rac1.  J Biol Chem 2004, 279(7):6196-6203.
47. Eng CH, Huckaba TM, Gundersen GG: The Formin mDia Regu-
lates GSK3{beta} through Novel PKCs to Promote Microtu-
bule Stabilization but Not MTOC Reorientation in Migrating
Fibroblasts.  Mol Biol Cell 2006.
48. Tao W, Pennica D, Xu L, Kalejta RF, Levine AJ: Wrch-1, a novel
member of the Rho gene family that is regulated by Wnt-1.
Genes Dev 2001, 15(14):1796-1807.
49. Karin M: The regulation of AP-1 activity by mitogen-activated
protein kinases.  J Biol Chem 1995, 270(28):16483-16486.
50. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B,
Davis RJ: Selective interaction of JNK protein kinase isoforms
with transcription factors.  Embo J 1996, 15(11):2760-2770.
51. Yujiri T, Fanger GR, Garrington TP, Schlesinger TK, Gibson S, John-
son GL: MEK kinase 1 (MEKK1) transduces c-Jun NH2-termi-
nal kinase activation in response to changes in the
microtubule cytoskeleton.  J Biol Chem 1999,
274(18):12605-12610.
52. Yujiri T, Ware M, Widmann C, Oyer R, Russell D, Chan E, Zaitsu Y,
Clarke P, Tyler K, Oka Y, Fanger GR, Henson P, Johnson GL: MEK
kinase 1 gene disruption alters cell migration and c-Jun NH2-
terminal kinase regulation but does not cause a measurable
defect in NF-kappa B activation.  Proc Natl Acad Sci U S A 2000,
97(13):7272-7277.
53. Smalley MJ, Sara E, Paterson H, Naylor S, Cook D, Jayatilake H, Fryer
LG, Hutchinson L, Fry MJ, Dale TC: Interaction of axin and Dvl-2
proteins regulates Dvl-2-stimulated TCF-dependent tran-
scription.  Embo J 1999, 18(10):2823-2835.
54. Lucas FR, Salinas PC: WNT-7a induces axonal remodeling and
increases synapsin I levels in cerebellar neurons.  Dev Biol 1997,
193:31-44.